Quantum Biopharma (QNTM) Payables (2018 - 2026)

Quantum Biopharma (QNTM) has 9 years of Payables data on file, last reported at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 12.98% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 12.98% YoY), and the FY2025 full-year result was $5.5 million, up 10.07% from the prior year.
• Payables fell to $3.9 million in Q1 2026, from $5.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $8.2 million in Q1 2022 to a low of $3.4 million in Q1 2025.
• A 5-year average of $5.7 million and a median of $5.5 million in 2025 frame the typical range for Payables.
• Across the five-year window, Payables tumbled 41.09% in 2023 and jumped 68.02% in 2025, its largest moves.
• Tracing QNTM's Payables over 5 years: stood at $7.4 million in 2022, then tumbled by 45.98% to $4.0 million in 2023, then grew by 24.45% to $5.0 million in 2024, then climbed by 10.07% to $5.5 million in 2025, then decreased by 29.02% to $3.9 million in 2026.
• Business Quant data shows QNTM's Payables at $3.9 million in Q1 2026, $5.5 million in Q4 2025, and $6.1 million in Q3 2025.